Moreover, GBM has been shown to mediate PD-L1/PD1 axis signaling via aberrant tumor expression of PD-L1, leading to attenuation of tumor infiltrating lymphocyte response and promotion of Treg expansion (35, 36). This evidence concerns the gene CD274 and neoplasm.